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ABBREVIATIONS 
ACR Acute cellular rejection 
A VM Arteriovenous malformation 
C-J Choledocho-jejunum 
CA Carcinoma 
CMV Cytomegalovirus 
DIC Disseminated intravascular coagulation 
D U Duodenal ulcer 
EBV Epstein Barr virus 
EU Esophageal ulcer 
EV Esophageal varices 
GIB Gastrointestinal bleed 
GU Gastric ulcer 
GV Gastric varices 
HA Hepatic artery 
HCC Hepatocellular carcinoma 
Hep Hepatitis 
J-J Jejuno-jejunum 
MW Mallory-Weiss 
NG Nasogastric 
OLTx Orthotopic liver transplant 
PBC Primary biliary cirrhosis 
PCR Polymerase chain reaction 
PHT Portal hypertensi on 
PHTG Portal hypertensive gastropathy 
POD Postoperative day 
RY Roux-en-Y 
SB Small bowel 
UNOS United Network for Organ Sharing 
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ABSTRACT 
To investigate the causes of gastrointestinal bleeding (GIB) and its impact on patient and graft 
survival after liver transplantation (OL Tx), adult patients among the first 1000 consecutive OL Tx 
under Tacrolimus comprised our study population. Of 834 patients who comprised our 
population, 74 had at least one bleeding episode, and 760 patients had no GIB. Patients with 
GIB had their bleeding episodes analyzed and those without GIB were used as controls. The 
mean age, gender, and UNOS status were similar in both groups. Endoscopy was done in 73 
patients with GIBand yielded a diagnosis in 60 (82.2%) who had a single (n=39) or multiple 
(n=21) GIB episodes. In the remaining 13 (17.8%) patients, the bleeding source was not 
identified. Ulcers (25) were the most common diagnosis, followed by enteritis (23), portal 
hypertensive lesions (15), RY bleeds (6), and miscellaneous (25). The majority (73%) of the 
GIB episodes occurred during the first postoperative trimester. The patient and graft survival 
were statistically lower in the GIB group compared with the rest. The adjusted relative risk of 
mortality and graft failure were increased by bleeding. In summary, endoscopy identified the 
source of GIB after OL Tx in most cases. The cumulative incidence of GIB was 8.9% for the 
study period. Ulcers were the most common cause of GIB. The onset of gastrointestinal 
bleeding after liver transplantation carried a decreased patient and graft survival. 
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INTRODUCTION 
Despite refinements In surgical techniques, the incidence of complications after liver 
transplantation remains significant. This reflects the degree of physical illness of the recipients as 
well as the technical demands of the operation (1-6). Bleeding is one of the operative (7) and 
postoperative (8, 9) complications reported after liver transplantation. Although postoperative 
bleeding has been described in a variety of clinical situations (8-17), the incidence and significance 
of gastrointestinal bleeding (GIB) after liver transplantation have yet to be determined. 
The onset of bleeding during (7) and after (9) transplantation increases early mortality, 
particularly when there are multiple episodes of bleeding or when the source of bleeding is not 
known. These patients are often subject to repeated surgical explorations (8, 9). Bleeding from 
lesions associated with portal hypertension after liver transplantation has been reported as a sign 
of thrombosis in the portal system (8, 10, 11, 18). In these studies, no reference is made to the 
histological status of the grafts at the time of bleeding, or whether or not portal hypertension 
represented graft dysfunction. There is also a lack of information on the long term outcome, the 
causes, and the precise incidence and impact of gastrointestinal bleeding on liver transplant 
recipients. Therefore, the aim of our study was to further define the incidence and the causes of 
gastrointestinal bleeding after liver transplantation, and to assess its impact on patient and graft 
survival. 
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PATIENTS AND METHODS 
Patients. The records of the first 1000 consecutive primary liver transplants performed since the 
introduction of Tacrolimus were retrospectively reviewed. Only adult (> 18 years old) patients 
were included. The patients were stratified according to UNOS classification (status 4 and 3, 
patients out of the hospital with limited activity; status 2, patients in the hospital; status 1, 
patients in the intensive care unit). Demographic data was collected, including: age, etiology of 
liver disease, the number, source, and timing of the bleeding episodes (as determined by 
endoscopic, operative, angiographic, or nuclear medicine reports), the number of transplants, and 
the causes of patient and graft loss. 
The diagnosis of gastrointestinal bleeding was confirmed with existing diagnostic operative, 
endoscopic, and/or radiological tests. For the purpose of this retrospective study, we adhered to 
the following criteria: 
- Bleeding episode: presence of hematemesis and/or melena, with or without hemodynamic 
instability, that required evaluation and testing. Available diagnostic procedures were considered 
part of the same bleeding episode if they were performed within the same 24 hour period. 
- Diagnostic endoscopy: reports that unequivocally described: i) active bleeding (i.e., varices, 
ulcers, mucosal lesions, etc.) or signs of recent bleeding (i.e. adherent clots); ii) blood in the 
gastrointestinal lumen and endoscopic evidence of portal hypertension (esophageal and/or gastric) 
with no other findings or active bleeding were classified a.s bleeding from portal hypertension; iii) 
bleeding mucosal lesions described using endoscopic terms of "esophagitis", "gastritis", or 
"duodenitis" were classified separately as 'enteritis' if there were no descriptions that would 
specifically described them as portal hypertensive lesions; iv) presence of blood in the small 
intestine without evidence of ulcers, enteritis, or portal hypertension in patients with Roux-en-Y 
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(RY) anastomosis were considered "possible RY bleeds" unless the source was directly 
visualized at endoscopy. v) endoscopic evidence of 'enteritis' and serological (early or late CMV 
antigens), or histological (inclusion bodies, specific immunoperoxidase staining, or PCR) evidence 
ofCMV infection at the time of the bleeding episode were classified as CMV enteritis. 
_ Non-diagnostic endoscopy: reports in which the signs of bleeding were not present, regardless 
of the nature of the endoscopic findings, including: i) portal hypertension without active bleeding 
or blood; ii) lack ofluminal blood in patients with RY anastomosis; iii) mucosal lesions (erosions 
or 'enteritis') with no signs of bleeding; iv) ulcers without active bleeding, clots, visible vessels, 
or signs of recent bleeding. 
The findings during the diagnostic and/or therapeutic endoscopic interventions were recorded for 
each patient during each bleeding episode and subsequently classified according to diagnosis. 
Immunosuppression. The primary immunosuppression was Tacrolimus, as previously reported 
in this group of patients (19). 
Statistics. Continuous variables are presented as the mean ± standard error, and categorical 
variables as proportions. The standard two-sample t-test was used to test differences between 
means, while differences in proportions were tested using Pearson's chi-square or Fisher's Exact 
test, if expected frequencies were less than five. The Wilcoxon Rank Sum test, a nonparametric 
equivalent to the standard two-sample t-test, was used for highly skewed data. 
The cumulative risk of the first episode of a GI bleed was computed using the Kaplan-Meier 
(Product-Limit) method. Risk estimates were calculated as I-S(t), where Set) is the cumulative 
probability of being event-free at time t. 
Patient survival was calculated from the date of liver transplantation until death, and primary 
graft survival from the date of liver transplantation until first retransplantation or death. Survival 
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curves were generated using the method of Feuer et al. (20) and compared by the Mantel-Byar 
chi-square test (21). This method produces a graphical representation of survival associated with 
a time dependent covariate. That is, the method compares survival for those patients who 
already had a GI bleed at time t to those who have never had a GI bleed and are still alive at time 
t. The choice oft is arbitrary. We chose 90 days, since the majority of cases (73%) occurred in 
this interval (see Results section). Cox's proportional hazards model was used to compute the 
relative risk (RR) of mortality for GI bleed, and 95% confidence intervals. The variable GI bleed 
was incorporated into Cox's model as a time-dependent covariate. Multivariate Cox regression 
was used to adjust the RR for UNOS status at time of transplantation, recipient age, gender, and 
etiology ofliver disease. 
Survival according to the cause of Gill was calculated from the date of first episode of Gill until 
death. The date of Gill was used as a reference date because the timing of the first episode was 
statistically similar for the different causes. Survival curves were generated using the Kaplan-
Meier (Product-Limit) method and compared by the log-rank test. 
All tests were two-tailed. A p-value ofless than 0.05 was considered statistically significant. 
March 29, 1 996 1 2 :04 PM 8 
GaStroi'1testinal bleeding after OLTx J. T -Minguilhin et at. 
RESULTS 
Among the first 1000 OLTx performed between August of 1989 and December of 1992, there 
were 834 adults. The mean age was 49.9 (range 18.1 to 76.2) years. The mean follow-up was 
47.9 (range 27.7 to 67.9) months. There were 330 (39.6%) women and 504 (60.4%) men. The 
UNOS classification prior to liver transplantation was status 4 or 3 in 120 (14.4%), status 2 in 
321 (38.5%), and status 1 in 393 (47.1 %) patients. The causes of liver disease in these patients 
included postnecrotic cirrhosis (25% viral, 3% autoimmune, and 1 % drug-induced and 
miscellaneous), alcoholic liver disease (23%), primary biliary cirrhosis (10%), cryptogenic 
cirrhosis (9%), primary liver tumors (9%), sclerosing cholangitis (7%), and other diagnoses 
(13%). 
Patients were excluded from the study if they had an unconfirmed diagnosis of blood loss (n=18), 
or if the source of blood loss was non-gastrointestinal (GI) (n=3). A total of 74/834 (8.9%) 
patients were identified who had at least one bleeding episode (range 1 to 5) from a GI source. 
The age, gender, and UNOS status of the 74 patients with Gill were similar to the ones in the 
760 patients without Gill (table 1), who therefore were used as a reference group in the survival 
analysis (figures 1 to 3). The etiology of the liver disease was similar in both groups (table 1). 
Overall causes of bleeding. Of the 74 patients with Gill, endoscopy was declined in one case. 
This patient had hematemesis, decreased hematocrit, and was managed conservatively. In three 
patients with RY biliary reconstruction, endoscopy was not performed during the first bleeding 
episode and a presumed diagnosis of bleeding RY was given. These three patients subsequently 
had other episodes of bleeding with endoscopic evaluations (tables 2 and 3). In the remaining 70 
patients, endoscopy was performed during the initial and subsequent bleeding episodes (table 3). 
There were 108 bleeding episodes evaluated with endoscopy (94 upper endoscopies and 22 
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colonoscopies, range of 1 to 4 procedures per bleeding episode). Therefore, including the patient 
who declined endoscopy, there were 109 bleeding episodes in the entire group (table 3). 
In 21 patients (including the 3 without initial endoscopic examination) there were multiple (one 
or more) bleeding episodes. In 39 patients, there was a single bleeding episode with an identified 
source at endoscopy. In 13 other patients, the source was not found despite endoscopy (table 
2). Therefore, endoscopic evaluation yielded a diagnosis in 60170 (85.7%) patients. The overall 
causes of bleeding according to episode are listed in table 3. Bleeding from ulcers was the most 
common diagnosis, followed by non-CMV enteritis (table 3), portal hypertensive lesions (tables 
3 and 4), bleeding RY anastomosis (tables 3 and 5), and miscellaneous (table 3). 
Time a/bleeding. The first (or only) bleeding episode occurred during the first three months after 
OLTx in 54 (73%) patients, from 3 months to 1 year in 9 (12%) patients, and after the first year 
in 11 (15%) patients. The cumulative incidence of bleeding at one year was 8%. A second 
bleeding episode occurred in 21 cases (at 268 ± 57 POD), a third episode in 11 cases (at 337 ± 87 
POD), a fourth episode in 2 cases (at 828 ± 443 POD), and a fifth episode in 1 case (at 1272 
POD). No significant differences (p=0.3147) were found in the median -range- time to bleeding 
in non-diagnostic bleeds (23 -2 to 591- days), single bleeds (26 -1 to 1306- days), or multiple 
bleeds (88 -2 to 885- days). 
Although more frequent during the first three months, bleeding from ulcers and enteritis was also 
seen during the late postoperative follow-up (see below). In the case of bleeding from portal 
hypertension, bleeding occurred either before POD 12 or after POD 270 (table 4). All RY bleeds 
occurred during the first three months after OLTx (table 5). 
Bleeding from ulcers. There were 25 bleeding episodes from bleeding diagnosed in 23 patients. 
Two patients had two bleeding episodes; the first had a gastric ulcer that bled at POD 82 and 
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116; the second also had a gastric ulcer at pod 140 and 1272. Active bleeding (with or without 
clots) was described in 9 episodes, of which a therapeutic intervention was performed in 7 cases 
[injection therapy alone (n=3), with heater probe (n=l) or bicap electrocautery (n=l), and bicap 
electrocautery alone (n=2)]. Adherent clots without active bleeding were described in 4 episodes, 
and pigmented lesions in 1 episode (none treated). A visible vessel with clot was described in 1 
episode (treated with injection therapy). Unspecified "stigmata of bleeding" was described in the 
remaining 10 episodes (one treated with injection therapy). 
Helicobacter pylori was not described in any of the pathology reports of 11 (44%) cases in 
which a biopsy was obtained. Although information on the use of steroids in these patients was 
previously available (19), there was insufficient data on the use of non-steroidal antiinflammatory 
drugs to further characterize these ulcers. Neither of the two patients with recurrent bleeds had 
any therapeutic intervention. Multiple ulcers were described in: four patients with gastric ulcers 
(2 ulcers in 3 patients and 3 ulcers in 1 patient); one patient with two duodenal ulcers; and three 
patients with esophageal ulcers (2 ulcers in 2 patients and 3 ulcers in 1 patient). The description 
of the size or location (i.e., antrum vs. corpus) of these ulcers was generally imprecise. Ulcers 
were also described in 10 patients with bleeding from other sources and although they were 
clearly described as non-bleeding additional endoscopic details were insufficient to further 
classify them. The median time to bleeding from ulcers was 22 (range 5-1306) days when they 
were the only source of bleeding and 129 (2-885) days when they occurred with other bleeding 
lesions, a non-significant difference (p=0.172). Most (52%) episodes of bleeding from ulcers 
occurred during the first three months, 16% occurred from the first trimester to one year, and 
32% episodes occurred after one year. In 6 patients, ulcers were found within the first two 
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postoperative weeks. The number of retransplants after the Gm in these 23 patients was 5 
(22%), and the number of deaths was 10 (43%). 
Bleedingfrom enteritis. There were 26 episodes of bleeding diagnosed in 25 patients. Histological 
sampling was performed in 13/26 (50%) of these episodes. One biopsy (colon) showed CMV 
inclusion bodies, and another (stomach) was positive for CMV by PCR. These two patients 
were classified in the miscellaneous group as having CMV enteritis (table 3). Therefore, there 
were 24 bleeding episodes in 23 patients with non-CMV enteritis. The median time to bleeding 
from enteritis was 57 (range 1-531) days when they were the only source of bleeding and 60 (2-
760) days if they occurred with other bleeding lesions (p=0.87). Most (46%) episodes occurred 
during the first three months, 38% occurred from the first trimester to one year, and 16% after 
one year. Five patients had bleeding within the first 2 postoperative weeks. The number of 
retransplants after the Gm in these 25 patients was 10 (40%), and the number of deaths was 10 
(40%). 
Bleeding from portal hypertension. Thirteen patients had bleeding from portal hypertensive 
lesions (varices, gastropathy, or both). Two groups of patients could be identified according to 
the time of bleeding (table 4). In seven patients, the bleeding occurred within the first 12 POD 
and all of them had portal hypertension (PHT) prior to OLTx (one required early 
retransplantation and another died after the bleed). In six other patients, the bleeding occurred 
after POD 270. Three (50%) of them required retransplantation (two after the bleeding episode), 
and three (50%) died. Patients requiring retransplantation were found to have cirrhosis (n=2) or 
HA thrombosis (n=l) with other graft findings such as acute rejection or hepatic necrosis (table 
4). 
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The bleeding was controlled with sclerotherapy (sodium morrhuate) in three patients, and one of 
them subsequently underwent band ligation. 
Additionally, PHT was described in 17 patients who bled from sources other than their portal 
hypertensive lesions. The graft histology in these patients after the endoscopic diagnosis of 
PHT also showed significant abnormalities ranging from hepatitis to cirrhosis (data not shown). 
The number of retransplants after the GIB in these 17 patients was 4 (23%), and the number of 
deaths was 5 (29%), respectively. Therefore, when bleeding (n=13) and non-bleeding PHT 
(n=17) were considered together, the postbleeding retransplantation rate was 7/30 (23%), and the 
mortality rate was 9/30 (30%). 
Bleeding Roux-en-Y anastomosis. Clinical suspicion ofRY bleeding existed in 10 patients (table 
5). Exploratory laparotomy was performed in 7 cases of whom 6 were found to have active 
bleeding. Bleeding sca.ns (n=2), but not angiography, were positive when performed before 
surgery (table 5). Endoscopy revealed luminal blood but failed to identify the precise source of 
bleeding at the anastomosis in 7 cases. Therefore, these endoscopies were classified as either non-
diagnositic or as 'possible RY' bleeds in the diagnostic group with multiple bleeds (table 2 and 5). 
The mean time of bleeding was 21 (range 3-87) days after OLTx. The rates of retransplantation 
and mortality were 40% and 30% respectively. 
Miscellaneous causes of bleeding. Bleeding from Mallory-Weiss tears, hemobilia (hepatic artery 
pseudoaneurysm, and post-liver biopsy), colonic polyps, hemorrhoids, A VMs, and trauma from 
nasogastric tubes occurred in 2 cases each. Additionally, in 4 bleeding episodes, endoscopy 
revealed the presence of blood in the gastric (n=2) or small intestinal (n=2) lumen without a 
specific source. None of these patients had RY reconstructions. The remaining bleeding 
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diagnoses occurred only once (table 3). Only three therapeutic interventions were recorded in 
this group (two for A VMs and one for a bleeding colonic polyp). 
Survival analysis. The overall primary patient and graft survival (Kaplan-Meier) in patients with 
GIB was lower (p < 0.00001) than the patients with no GIB. Since most of the bleeding 
episodes occurred during the first three months after OLTx, the Mantel-Byar chi-square test 
showed a lower (p<O.OOOOl) survival (figures 1a and 1b) in patients who had a GIB within the 
first three months compared to those patients who never had a GIB and survived to 3 months 
(see Statistical Analysis section). The adjusted relative risk (RR) of patient mortality for GIB 
was 4.2 (95% CI = 2.9-6.0). The adjusted RR of graft failure for GIB was 3.4 (95% CI = 2.3-
4.9). 
Patients with no identifiable sources ofGIB at endoscopy (n=13) and with no endoscopy (n=l) 
fared better than patients with specific endoscopic diagnoses. Multiple bleedings had worse (log 
rank, p=0.3557) outcome than single bleeds (figure 2). Survival in patients bleeding from a single 
source (i.e., ulcers only) was better than in patients in which the sources were multiple (i.e., 
ulcers and others), although the differences did not reach statistical significance (figure 3). There 
were no significant differences in survival (p=0.364, log rank) between the various types of 
bleeding lesions (ulcers vs. enteritis vs. portal hypertensive lesions). 
The outcome of bleeds occurring in the first three postoperative months showed an adjusted RR 
of mortality of2.91 (95% CI = 1.86-4.55), and of primary graft failure of 2.47 (95% CI = 1.55-
3.93). The outcome of bleedings occurring from 4 to 12 months showed an adjusted RR of 
mortality of 7.84 (95% CI = 3.80-16.19), and of primary graft failure of 8.80 (95% CI = 4.24-
18.23). The outcome of bleedings occurring after the first year showed an adjusted RR of 
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mortality of26.84 (95% CI = 10.47-68.84), and of primary graft failure of 18.84 (95% CI = 6.23-
52.26). 
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DISCUSSION 
The occurrence of bleeding has long been recognized as a complication following liver 
transplantation (8). Some of the reported sources of blood loss in recipients of liver transplants 
are vascular anastomotic leaks (8, 9), persistent coagulopathy (8, 9), hemobilia (8, 13), viral 
(CMV and EBV) gastroduodenitis (9, 12), RY anastomotic bleeds (9, 7), esophageal perforations 
(8, 12), and PHT due to splenic (11, 18) or portal (8, 10) vein thrombosis, and various other 
vascular complications (9, 15). 
The presence of gastrointestinal bleeding is not an infrequent indication for initiating a diagnostic 
(8) or therapeutic (14) endoscopic evaluation in liver transplant recipients. Bleeding from a RY 
anastomosis during the first two weeks has been attributed to incomplete hemostasis of the 
mucosa at the jejunojejunostomy site, facilitated by the reabsorption of the sutures, poor 
nutritional status, presence ofPHT, and use of immunosuppressants (9). Gastrointestinal blood 
loss after the first postoperative weeks has been attributed to cytomegalovirus gastroenteritis (9), 
and more infrequently to other interventions such as liver biopsy (13). Some other reports have 
described esophageal perforations (8, 12), and PHT due to splenic (11, 18) or portal (8, 10) vein 
thrombosis in the early postoperative period. The onset of bleeding from PHT has been 
mentioned as a sign of thrombosis in the splachnic vascular territory (8, 10, 11, 18) but not as a 
sign of graft dysfunction. Otherwise, there is no information about other gastrointestinal sources 
of blood loss in these patients. With the exception ofRYbleeds (14), the gastrointestinal sources 
of bleeding had not been analyzed in the previous studies. Furthermore, although patients with 
gastrointestinal bleeding had been reported as having an increased morbidity (8), the survival of 
patients with OLTx complicated by gastrointestinal bleeding has not been fully determined. 
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In the present study, we analyzed the early and late causes of gastrointestinal bleeding after liver 
transplantation. We studied 834 adults from the first 1000 patients treated with Tacrolimus 
since preliminary data on survival and other adverse events in these patients was already 
available (19). No statistical differences in terms of age, gender, and UNOS status prior to 
transplantation were seen between patients with and without GIB. The diagnoses of the pre-
transplant liver disease were also similar in these two groups. In the majority of cases, an 
accurate clinical diagnosis ofGIB existed since only 3 patients were found not to have had GIB 
after reviewing their records. Endoscopy was declined in one case, and was not performed 
initially in 3 others. Therefore, there were endoscopic reports available for analysis in the 
majority of the bleeding episodes. In most of these patients, endoscopy was the diagnostic 
intervention. Although the terms "gastritis", "duodenitis", etc., are of histologic nature and 
require biopsy, we created the group 'enteritis' to separate these from the other groups, despite 
the lack of histological confirmation. In contrast with previous observations (18), the most 
common bleeding lesions found in these patients were ulcers, followed by hemorrhagic enteritis 
and portal hypertensive lesions in a similar way as described in non-transplant patients (22). RY 
bleeds were confirmed in 6 cases and probably existed in an additional 4, making it the fourth 
most common diagnosis. Non-bleeding ulcers, enteritis, and portal hypertensive lesions were 
also seen in 10,28, and 17 bleeding episodes respectively, in conjunction with other diagnoses. 
The incidence of bleeding was highest during the first postoperative trimester for the entire 
group. Bleeding from ulcers and enteritis also occurred after the first trimester. In the case of 
bleeds from portal hypertensive lesions, two distinct periods were seen: early bleeding most 
likely representing lack of resolution of preoperative PHT, and late bleeding representing de novo 
PHT. Bleeding from RY anastomosis was an early postoperative event. 
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In patients who had bleeding ulcers, the data on the incidence of Helicobacter pylori infection was 
not sufficient to characterize them. Details on the use of non-steroidal anti-inflammatory drugs, 
tests for detecting helicobacter pylori, or other risk factors for peptic ulcer disease were 
insufficient to allow further classification. Seven of the nine patients with actively bleeding 
ulcers underwent therapeutic intervention during the endoscopy. In the other two not receiving 
treatment, there was recurrence of the GIB. Most ulcers without active bleeding but with clots, 
visible vessels, or other stigmata of bleeding did not have therapeutic intervention. This probably 
reflects the lack of unifonn consensus on endoscopic treatments in these type of ulcers that 
existed at the time in which the bleeds took place. 
In patients bleeding from enteritis, histologic data was not available in most cases. There were 
only two patients in which CMV was identified as the pathogen, yielding a rate that is low 
compared to previous reports (9). The etiology of the enteropathy in the other cases remained 
undetermined, although there were no recurrences of bleeding and no antiviral therapy was 
admini stered. 
In patients bleeding from portal hypertensive lesions, the rate of graft failure and 
retransplantation was high (up to 50%). Overall, the onset of PHT, (with or without bleeding) 
reflected poor graft function based on the findings at histology, ranging from hepatitis to 
cirrhosis. 
In the present series of patients, bleeding from RY anastomosis was addressed surgically in 6 
cases. In three other cases, the source of bleeding was not visualized endoscopically, but they 
subsided with conservative management. In one case, endoscopy and laparotomy failed to reveal 
the source of bleeding (table 5). 
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According to the survival analysis, bleeding with an identified source at endoscopy carried a 
worse prognosis than bleeding with no source, and multiple bleeding episodes carried worse 
survival than single bleeding episodes. With respect to diagnosis, ulcers, enteritis, or PHT, when 
they were the only source of bleeding, had better outcome than if they occurred with other 
lesions. However, none of these differences reached statistical significance. 
The time in which Gill took place influenced the outcome, with worse survival for Gill episodes 
occurring after the first postoperative year regardless of etiology. Bleeding from portal 
hypertensive lesions was seen with graft dysfunction by histological criteria. Whether ulcers and 
enteritis also reflected graft dysfunction is unknown since, unlike patients bleeding from portal 
hypertensive lesions, most of these cases had no liver biopsies. 
In summary, the results of this study show ulcers as the most common cause of gastrointestinal 
bleeding after liver transplantation, followed by hemorrhagic enteritis, portal hypertensive 
lesions, and RY bleeds. The patient and graft survival when gastrointestinal bleeding was present 
were worse than in patients without bleeding. Early bleeding from PHT was seen with graft 
dysfunction but probably represented persistent pre-transplant PHT. Late bleeding from PHT 
was seen with a significant rate of graft dysfunction and loss, retransplantation, and death. 
Multiple episodes and sources of bleeding were associated with poor patient survival. Attempts 
at characterizing the nature (peptic vs. non-steroidal vs. stress) of the gastrointestinal ulcers after 
liver transplantation seem justified since they are a common cause of Gill, and the evaluation 
may affect the therapeutic options offered to these patients. In the present study, the nature of 
the hemorrhagic mucosal lesions described as enteritis remains undefined. It is possible to 
speculate that they could also be a sign of graft dysfunction. Histological sampling to determine 
the nature of the enteritis and to exclude CMV or other viral pathogens needs to be considered 
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whenever biopsies can be safely obtained. Evidence of portal hypertension during endoscopy 
should prompt a thorough functional assessment of the liver graft since it seems to be associated 
with a significant rate of graft dysfunction and failure. 
In conclusion, gastrointestinal bleeding after liver transplantation seems to be an indicator of poor 
patient and graft survival. Late postoperative bleeding appears to be particularly ominous. 
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Gastrointestinal bleeding after OLTx J. T-Minguillan et aJ. 
FIGURE LEGENDS 
Figure 1. Survival of patients (la) and grafts (lb) with gastrointestinal bleeding (GIB) during 
the first postoperative trimester compared to patients with no GIB (p < 0.00001 Mantel-
Byar chi square test, see text for details). 
Figure 2. Survival after liver transplantation in patients with gastrointestinal bleeding according 
to the type of endoscopy. 
Figure 3. Survival after liver transplantation in patients with gastrointestinal bleeding according 
to the source of bleeding. 
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